This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Centre Hospitalier Universitaire Vaudois (c.h.u.v.). Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Denise Nardelli Haefliger: Innovator in Pharmaceutical Composition
Introduction
Denise Nardelli Haefliger is a notable inventor based in Lausanne, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancer. Her innovative work focuses on developing compositions that can potentially improve patient outcomes.
Latest Patents
Denise holds 1 patent related to a pharmaceutical composition comprising a live attenuated non-recombinant mutant of serovar strain and/or a non-viable attenuated non-recombinant mutant of serovar strain for the treatment of cancer recurrence or progression. This invention is particularly aimed at addressing bladder cancer, showcasing her commitment to advancing cancer treatment options.
Career Highlights
Throughout her career, Denise has worked with esteemed institutions such as the Centre Hospitalier Universitaire Vaudois (CHUV). Her role in these organizations has allowed her to contribute to significant advancements in medical research and patient care.
Collaborations
Denise has collaborated with professionals like Sonia Domingos Pereira and Patrice Jichlinski, enhancing her research through teamwork and shared expertise.
Conclusion
Denise Nardelli Haefliger is a pioneering inventor whose work in pharmaceutical compositions is making strides in cancer treatment. Her dedication to innovation continues to inspire advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile